Chlorpheniramine maleate 1 mg/ML / dihydrocodeine bitartrate 0.6 mg/ML / phenylephrine hydrochloride 4 mg/ML Oral Solution [Baltussin]
RxNorm 1236083

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 1236083 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: chlorpheniramine maleate 1 mg/ML / dihydrocodeine bitartrate 0.6 mg/ML / phenylephrine hydrochloride 4 mg/ML Oral Solution [Baltussin].

The following semantic concepts and normalized strings are associated with this clinical entity:

SY
Baltussin (chlorpheniramine maleate 5 mg / dihydrocodeine bitartrate 3 mg / phenylephrine hydrochloride 20 mg) per 5 mL Oral Solution
AUI:4227241
View
SBD
Chlorpheniramine maleate 1 mg/ML / dihydrocodeine bitartrate 0.6 mg/ML / phenylephrine hydrochloride 4 mg/ML Oral Solution [Baltussin]
AUI:12360244
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SY

Synonym (SY):
Baltussin (chlorpheniramine maleate 5 mg / dihydrocodeine bitartrate 3 mg / phenylephrine hydrochloride 20 mg) per 5 mL Oral Solution
(Atom ID: 4227241)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Baltussin (chlorpheniramine maleate 5 MG / dihydrocodeine bitartrate 3 MG / phenylephrine hydrochloride 20 MG) per 5 ML Oral Solution
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1236083
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
4227241
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
1236083
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
SBD

Semantic Branded Drug (SBD):
Chlorpheniramine maleate 1 mg/ML / dihydrocodeine bitartrate 0.6 mg/ML / phenylephrine hydrochloride 4 mg/ML Oral Solution [Baltussin]
(Atom ID: 12360244)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
chlorpheniramine maleate 1 MG/ML / dihydrocodeine bitartrate 0.6 MG/ML / phenylephrine hydrochloride 4 MG/ML Oral Solution [Baltussin]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
1236083
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12360244
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SBD
Semantic Branded Drug (Ingredient + Strength + Dose Form + Brand Name)
Source Code
1236083
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN AI
{1090530} 142429
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AI
{1234940} 104966
RXCUI of BOSS Active Ingredient preceded by RXCUI of SCDC responsible for value
RXN AM
{1090530} 2400
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN AM
{1234940} 23088
RXCUI of BOSS Active Moiety preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1090530} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN BOSS FROM
{1234940} AI
Source of BOSS as either from the active ingredient (AI) or the active moiety (AM) preceded by RXCUI of SCDC responsible for value
RXN OBSOLETED
04/30/2020
Date the RxNorm atom became obsolete
RXTERM FORM
Sol
The RxTerm dose form name for this drug